Last reviewed · How we verify
NCT05860153
Intermittent Levetricetam in Treatment of Febrile Convulsions
NA trial testing Levetiracetam in Febrile Convulsion in 100 participants. Status unknown.
1 January 2024
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 100 |
| Start date | 1 June 2023 |
| Primary completion | 1 January 2024 |
| Estimated completion | 1 August 2024 |
Drugs / interventions tested
- Levetiracetam (levetiracetam) — full drug profile →
- Diazepam (diazepam) — full drug profile →
Conditions studied
- Febrile Convulsion — all drugs for Febrile Convulsion →
Sponsor
Assiut University
Who can join
Adults 6 Months to 36 Months, any sex, with Febrile Convulsion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The American Academy of Pediatrics (AAP) in 2011 published a clinical practice guideline defining a febrile seizure as "a seizure accompanied by fever (temperature ≥ 100.4°F or 38°C by any method), without central nervous system infection, that occurs in infants and children 6 through 60 months of age." Febrile seizures are further classified as simple (generalized in onset, last less than 15 minutes, and do not occur more than once in 24 hours.) or complex (FS duration longer than 15 min, repeated convulsions within the same day, and focal seizure activity or focal findings during the postictal period.).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05860153
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Levetiracetam
Trials testing the same drug.
- NCT07490769 — Levetiracetam Three Times Daily in Epilepsy · Phase 3 · recruiting
- NCT07072624 — Early Post-Traumatic Seizures Prevention Trial (E-PTS Trial) · Phase 4 · recruiting
- NCT07046611 — Ketamine and Levetiracetam as Second-line Antiseizure Medication for Status Epilepticus in Children · Phase 2, PHASE3 · recruiting
- NCT06773364 — Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial · Phase 3 · recruiting
- NCT07052136 — Efficacy Comparison Between Levetiracetam and Valproic Acid in Pediatric Patients With Status Epilepticus · NA · completed
Other recruiting trials for Febrile Convulsion
Currently open trials in the same condition.
- NCT07027501 — The Evaluation of the Effectiveness of Febrile Seizure Training Given to Parents · NA · active not recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05860153 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 16 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05860153.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing